TNF and plasma cell myeloma: In the past two decades, blockage of TNF-α has been clinically applied in the treatment of inflammatory diseases, including rheumatoid arthritis, multiple myeloma, and psoriatic arthritis [31–33], and remarkable therapeutic effects have been observed.